Myelodysplastic syndrome: An inability to appropriately respond to damaged DNA?

Ting Zhou, Paul Hasty, Christi A. Walter, Alexander J.R. Bishop, Linda M. Scott, Vivienne I. Rebel

Research output: Contribution to journalReview article

24 Scopus citations

Abstract

Myelodysplastic syndrome (MDS) is considered a hematopoietic stem cell disease that is characterized by abnormal hematopoietic differentiation and a high propensity to develop acute myeloid leukemia. It is mostly associated with advanced age, but also with prior cancer therapy and inherited syndromes related to abnormalities in DNA repair. Recent technologic advances have led to the identification of a myriad of frequently occurring genomic perturbations associated with MDS. These observations suggest that MDS and its progression to acute myeloid leukemia is a genomic instability disorder, resulting from a stepwise accumulation of genetic abnormalities. The notion is now emerging that the underlying mechanism of this disease could be a defect in one or more pathways that are involved in responding to or repairing damaged DNA. In this review, we discuss these pathways in relationship to a large number of studies performed with MDS patient samples and MDS mouse models. Moreover, in view of our current understanding of how DNA damage response and repair pathways are affected by age in hematopoietic stem cells, we also explore how this might relate to MDS development.

Original languageEnglish (US)
Pages (from-to)665-674
Number of pages10
JournalExperimental Hematology
Volume41
Issue number8
DOIs
StatePublished - Aug 1 2013

    Fingerprint

ASJC Scopus subject areas

  • Molecular Biology
  • Hematology
  • Genetics
  • Cell Biology
  • Cancer Research

Cite this